Molecular Brain Imaging and the Neurobiology and Genetics of Schizophrenia

Pharmacopsychiatry

Volumn 36, Issue SUPPL. 3, 2003, Pages

  Heinz, A ^a   Romero, B ^a   Gallinat, J ^a   Juckel, G ^a   Weinberger, D R ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

COMT genotype; Dopamine; fMRI; Neurodevelopment; PET; SPECT

Indexed keywords

AMPHETAMINE; CATECHOL METHYLTRANSFERASE; DOPA; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; FLUORINE 18; HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ANHEDONIA; APATHY; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN SIZE; COGNITION; CONFERENCE PAPER; DNA POLYMORPHISM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG EFFECT; DRUG POTENCY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EVOKED AUDITORY RESPONSE; FRONTAL CORTEX; GENOTYPE; GLUCOSE UTILIZATION; HEREDITY; HIPPOCAMPUS; HUMAN; LIMBIC SYSTEM; MEMORY DISORDER; MENTAL TASK; MOOD DISORDER; NEGATIVE SYNDROME; NEUROBIOLOGY; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHIATRIC DIAGNOSIS; PSYCHOMOTOR DISORDER; PSYCHOSIS; RECEPTOR BLOCKING; SCHIZOPHRENIA; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; TEMPORAL LOBE; THALAMUS; WORKING MEMORY;

ANIMALS; BRAIN; CORPUS STRIATUM; DIAGNOSTIC IMAGING; DOPAMINE; GENOTYPE; HUMANS; LIMBIC SYSTEM; PREFRONTAL CORTEX; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0347003606     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R et al. From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 2000; 97: 8104-8109
2. Akil M, Kolachana B, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. Catechol-O-Methyltransferase genotype and dopamine regulation in human brain. J Neurosci 2003; 23: 2008-2013
3. Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, Bachevalier J, Frank JA, Egan M, Weinberger DR. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 1999; 45: 660-667
4. Bleuler E. Dementia praecox oder die Gruppe der Schizophrenien. Springer, Berlin: 1911
5. Blackwood DH, Glabus MF, Dunan J, O'Carroll RE, Muir WJ, Ebmeier KP. Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300. Br J Psychiatry 1999; 175: 357-366
6. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 1997; 94: 2569-74
7. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 1999; 9: 20-26
8. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10: 1078-92
9. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991; 11: 1907-1917
10. Dao-Castellana MH, Paillere-Martinot ML, Hantraye P, Attar-Levy D, Remy P, Crouzel C, Artiges E, Feline A, Syrota A, Martinot JL. Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res 1997; 23: 167-174
11. Donchin E, Coles MGH. Is the P300 component a manifestation of context updating? Behavioral Brain Science 1988; 11: 357-374
12. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001; 98: 6917-6922
13. Ford JM, Mathalon DH, Whitfield S, Faustman WO, Roth WT. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry 2002; 51: 485-492
14. Gallinat J, Riedel M, Juckel G, Sokullu S, Frodl T, Moukhtieva R et al. P300 and symptom improvement in schizophrenia. Psychopharmacology (Berl) 2001; 158: 55-65
15. Gallinat J, Mulert C, Bajbouj M, Herrmann WM, Schunter J, Senkowski D et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 2002; 17: 110-127
16. Gallinat J, Sander T, Bajbouj M, Schlattmann P, Xu K, Ferro EF et al. Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003; 54: 40-48
17. Gilbertson MW, van Kammen DP. Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia. Biol Psychiatry 1997; 42: 585-595
18. Goldberg TE, Weinberger DR. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies. J Clin Psychiatry 1996; 57 Suppl. 9: 62-65
19. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ, Alpert NM. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1998; 1: 318-323
20. Hegerl U, Juckel G, Müller-Schubert A, Pietzcker A, Gaebel W. Schizophrenics with small P300: a subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia? Acta Psychiatr Scand 1995; 91: 120-125
21. Heinz A, Knable MB, Coppola R, Gorey JG, Jones DW, Lee KS, Weinberger DR. Psychomotor slowing, negative symptoms and dopamine receptor availability IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophr Res 1998; 31: 19-26
22. Heinz A, Saunders RC, Kolachana BS, Jones DW, Gorey JG, Bachevalier J, Weinberger DR. Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage. Synapse 1999; 32: 71-79
23. Heinz A, Weinberger DR. Schizophrenia: The neurodevelopmental hypothesis. Current concepts in psychiatry. (Psychiatrie der Gegenwart). Springer, Berlin: 2000: p. 89-104
24. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia/ psychopathological and behavioral correlates. Eur Psychiatry 2002; 17: 9-16
25. Heinz A, Romero B, Weinberger DR. Functional mapping with Single Photon Emission Computed Tomography (and Positron Emission Tomography). In: Lawrie, Johnstone, Weinberger, editors. Brain Imaging in Schizophrenia. Part II - Functional Neuroimaging/Chapter 8. Oxford University Publications, 2003a; (in press)
26. Hietala J, Syvalahti E, Vilkman H, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Eronen E, Ruotsalainen U, Salokangas RK. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 1999; 35: 41-50
27. nd Rev. 2003
28. Jackson JH. Die Croon-Vorlesungen über Aufbau und Abbau des Nervensystems. Berlin: 1927
29. Juckel G, Mendlin A, Jacobs BL. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression. Neuropsychopharmacology 1999; 21: 391-398
30. Juckel G, Müller-Schubert A, Gaebel W, Hegerl U. Residual symptoms and P300 in schizophrenic outpatients. Psychiatry Res 1996; 65: 23-32
31. Juckel G, Reischies FM, Müller-Schubert A, Vogel AC, Gaebel W, Hegerl U. Ventricle size and P300 in schizophrenia. Eur Arch Psychiatry Clin Neurosci 1994; 243: 352-354
32. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 2000; 48: 627-640
33. Kotrla KJ, Weinberger DR. Brain imaging in schizophrenia. Annu Rev Med 1995; 46: 113-122
34. Laruelle M, Innis RB. Images in neuroscience. SPECT imaging of synaptic dopamine. Am J Psychiatry 1996b; 153: 1249
35. Laruelle M, Iyer RN, al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 1997; 25: 1-14
36. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000; 48: 99-109
37. Marenco S, Weinberger DR. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 2000; 12: 501-527
38. Mattay VS, Berman KF, Ostrem JL, Esposito G, Van Horn JD, Bigelow LB, Weinberger DR. Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci 1996; 16: 4816-4822
39. 158-met genotype and individual variation in the brain response to amphetamine. PNAS 2003; 100: 6168-6191
40. McCarley RW, Salisbury DF, Hirayasu Y, Yurgelun-Todd DA, Tohen M, Zarate C et al. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry 2002; 59: 321-331
41. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002; 5: 267-271
42. Molnar M. On the origin of the P3 event-related potential component. Int J Psychophysiology 1994; 17: 129-144
43. Norman RM, Malla AK, Williamson PC, Morrison-Stewart SL, Helmes E, Cortese L. EEC coherence and syndromes in schizophrenia. Br J Psychiatry 1997; 170: 411-415
44. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634-646
45. Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, Bachneff S, Cumming P, Diksic M, Cyve SE et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A 1994; 91: 11651-11654
46. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18: 247-291
47. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nautre 1998; 393: 169-171
48. Schacter DL, Alpert NM, Savage CR, Rauch SL, Albert MS. Conscious recollection and the human hippocampal formation: evidence from positron emission tomography. Proc Natl Acad Sci U S A 1996; 93: 321-325
49. Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A. Psychopathological correlates of reduced dopamine receptor sensitivity in depression schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 2001; 34: 66-72
50. Schultz W, Apicella P, Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurose 1993; 13: 900-913
51. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669
52. Weinberger DR, Bergman KF, Illowsky BP. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 1988; 45: 605-615
53. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 1992; 149: 890-897
54. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 1995; 16: 87-110
55. Weinberger DR, Egan MF, Bertolino A, Callicot JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001; 50: 825-844